Merck’s at-home antiviral COVID-19 pill approved by US regulator
Molnupiravir's approval comes a day after the FDA cleared a more effective competing antiviral pill from Pfizer.Molnupiravir's approval comes a day after the FDA cleared a more effective competing antiviral pill from Pfizer.